Lupin announces launch of diagnostics business
Mumbai-based pharma major Lupin has announced the launch of Lupin Diagnostics in India. As part of its strategy to provide integrated healthcare in India, Lupin Diagnostics, a wholly owned subsidiary of Lupin, has formally commenced operations. With healthcare playing an increasingly important role, Lupin Diagnostics’ goal is to provide quality diagnostics services to doctors, patients and consumers. The company has established a state-of- the-art 45,000 sq. ft National Reference Laboratory in Navi Mumbai. With world-class equipments, experienced doctors assisted by trained technologists, and stringent quality control protocols, Lupin Diagnostics will provide a comprehensive range of diagnostic tests. These include molecular diagnostics, cytogenetics, flow cytometry, microbiology, serology, histopathology and cytology, haematology, immunology, amongst others. In the next three years, the company plans to set up 100+ labs.